Search research articles
Contact Us
Filters
Showing results (221-230 of 443) with videos related to
Page
of 45
Sort By:
British Journal of Haematology
|
April 10, 2021
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia
Mohamed A Kharfan-Dabaja, Myriam Labopin, Eolia Brissot, et al.
Haematologica
|
June 22, 2014
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial
Patrice Chevallier, Myriam Labopin, Gérard Socié, et al.
Bone Marrow Transplantation
|
May 10, 2023
Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia-a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Giuliano Filippini Velázquez, Myriam Labopin, Johanna Tischer, et al.
Journal of Hematology & Oncology
|
May 4, 2021
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
Bhagirathbhai Dholaria, Myriam Labopin, Jaime Sanz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 26, 2017
Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission
Kristin M Page, Myriam Labopin, Annalisa Ruggeri, et al.
Leukemia & Lymphoma
|
October 12, 2020
Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMT
Thomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Leukemia
|
August 1, 2019
Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT
Maria H Gilleece, Myriam Labopin, Bipin N Savani, et al.
Bone Marrow Transplantation
|
December 13, 2023
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Haematologica
|
October 21, 2016
Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant
Annalisa Ruggeri, Yuqian Sun, Myriam Labopin, et al.
Bone Marrow Transplantation
|
May 8, 2020
COVID-19 outcomes in patients with hematologic disease
Florent Malard, Alexis Genthon, Eolia Brissot, et al.
Page
of 45
Search research articles
Search
Showing results (221-230 of 443) with videos related to
Sort By:
Page
of 45
British Journal of Haematology
|
April 10, 2021
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia
Mohamed A Kharfan-Dabaja, Myriam Labopin, Eolia Brissot, et al.
Haematologica
|
June 22, 2014
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial
Patrice Chevallier, Myriam Labopin, Gérard Socié, et al.
Bone Marrow Transplantation
|
May 10, 2023
Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia-a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Giuliano Filippini Velázquez, Myriam Labopin, Johanna Tischer, et al.
Journal of Hematology & Oncology
|
May 4, 2021
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
Bhagirathbhai Dholaria, Myriam Labopin, Jaime Sanz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 26, 2017
Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission
Kristin M Page, Myriam Labopin, Annalisa Ruggeri, et al.
Leukemia & Lymphoma
|
October 12, 2020
Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMT
Thomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Leukemia
|
August 1, 2019
Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT
Maria H Gilleece, Myriam Labopin, Bipin N Savani, et al.
Bone Marrow Transplantation
|
December 13, 2023
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Haematologica
|
October 21, 2016
Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant
Annalisa Ruggeri, Yuqian Sun, Myriam Labopin, et al.
Bone Marrow Transplantation
|
May 8, 2020
COVID-19 outcomes in patients with hematologic disease
Florent Malard, Alexis Genthon, Eolia Brissot, et al.
Page
of 45